Pyrimidine tract binding protein and La autoantigen interact differently with the 5′ untranslated regions of lentiviruses and oncoretrovirus mRNAs
Retrovirus genomic mRNA exhibits a several hundred nucleotides-long untranslated region (5′ UTR) which encloses many control elements required for retrovirus replication. In addition, this 5′ UTR contains translation regulatory elements, such as internal ribosome entry sites (IRESes) that have been...
Gespeichert in:
Veröffentlicht in: | FEBS letters 2001-02, Vol.490 (1), p.54-58 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Retrovirus genomic mRNA exhibits a several hundred nucleotides-long untranslated region (5′ UTR) which encloses many control elements required for retrovirus replication. In addition, this 5′ UTR contains translation regulatory elements, such as internal ribosome entry sites (IRESes) that have been described in oncoretroviruses, as well as in lentiviruses. UV cross-linking experiments suggested that the pyrimidine tract binding protein (PTB), a cellular protein known to regulate the activity of several picornaviral IRESes, binds to human T-cell leukemia virus (HTLV)-I RNA but not to lentiviral human immunodeficiency virus (HIV)-1, HIV-2 or simian immunodeficiency virus RNAs. To calculate the affinity of such RNA–protein interactions, we developed a new method based on the BIAcore technology. The absence of affinity of PTB for lentiviral RNAs was confirmed, whereas its affinity for HTLV-I RNAs was 1000-fold lower than for picornaviral RNAs. The BIAcore technology also revealed a significant affinity of the La autoantigen, previously described for its involvement in translational control of viral mRNAs, for HIV-1 and HTLV-I RNAs. Addition of recombinant PTB to in vitro translation experiments weakly enhanced translation initiation in the presence of HTLV-I IRES, suggesting that such an IRES requires additional
trans-acting factors. |
---|---|
ISSN: | 0014-5793 1873-3468 |
DOI: | 10.1016/S0014-5793(01)02137-8 |